Pathologic characteristics of drug-induced lung disease.
about
Statin-induced lung injury: diagnostic clue and outcomeSuppression of expression of heat shock protein 70 by gefitinib and its contribution to pulmonary fibrosisPharmacological Threat to Lungs: A Case Series and Literature Review.Epoprostenol-associated pneumonitis: diagnostic use of a T-cell proliferation assay.Drug induced interstitial lung disease.Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project.Granulomatous interstitial pneumonia induced by the intake of rice bran pickles: a rare subtype of pulmonary manifestation associated with food allergy.Relapsing pneumonitis due to two distinct inhibitors of the MAPK/ERK pathway: report of a case.Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens.Methotrexate pulmonary toxicity.S-1-induced lung injury combined with pneumocystis pneumoniaAcute granulomatous lupus pneumonitis: the first case report.Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.Pleuroparenchymal fibroelastosis and non-specific interstitial pneumonia: frequent pulmonary sequelae of haematopoietic stem cell transplantation.Pneumonitis with Diffuse Alveolar Hemorrhage Induced by Sho-seiryu-to.Mesalazine-induced lung fibrosisAmoxicillin-Induced Eosinophilic Pneumonia with Granulomatous Reaction: Discrepancy between Drug-Induced Lymphocyte Stimulation Test Findings and the Provocation Drug Test.Diphenylhydantoin (phenytoin)-induced chronic pulmonary disease.Incidence and aetiologies of pulmonary granulomatous inflammation: a decade of experience.Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis.Baclofen systemic toxicity: Experimental histopathological and biochemical study.A Case of Seasonal Influenza Vaccine-induced Pneumonitis Presenting with Multiple Pulmonary Nodules.Suspected drug-induced infiltrative lung disease culminating in acute respiratory failure in a dog treated with cytarabine and prednisone.
P2860
Q26822368-5C69A77E-7BBA-442A-86FA-C6261041D66BQ28477887-CEA336D5-9F7A-42D9-95E2-942300F41C21Q33787981-E4F96D25-ADC8-427A-8950-8B737BFCF79CQ34079565-D30B0CB0-8838-4BC9-9893-4991CDEB1364Q34641494-81C2D0EE-4969-48D3-BF99-1F2BA6941A03Q34767756-13B2EB1A-1E75-46A5-A07D-128D8DB158EBQ35467106-1D820B75-83A0-4920-9B71-42612585B1ECQ35813117-FA2FD2A0-B2DB-41BA-8534-496CC254CBE9Q35935114-6C7282AF-9661-4D73-A7FD-A39DCB311C49Q36191039-7ACEF413-38B0-40BA-9BB1-9F875444B98DQ36705272-BFCC9B6B-C599-4CA4-8DD4-228D4017BE60Q36790801-7903D607-DF74-43E0-A082-7598C2EC05A8Q37954366-1A223703-C45A-469E-9DA7-E083BA0249E9Q38252443-82BB4777-CD24-4E00-93BF-22012A2E9FC9Q40040101-F9495D73-17EE-43F2-96BC-A1A856773CA3Q40441220-7441DDDB-C4BD-41BD-91E7-478C339C7B62Q40447784-B951BD20-8223-4CC6-A8CB-481124E15C97Q40759878-12BACC8A-1899-4DF2-B7CA-339156A36BABQ41686342-430E3EAF-2582-4351-B0E4-D0859C6FA255Q43057764-54CD5FFB-B152-4580-B58B-D98F03B7065AQ46737082-6E39198F-4937-4A05-9FCC-98A2D285C621Q47726083-00A77841-118D-41EF-B284-488FDC3EF4B0Q47957192-2A7F377E-01D4-45D1-871D-B51FCE4D3D62
P2860
Pathologic characteristics of drug-induced lung disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pathologic characteristics of drug-induced lung disease.
@ast
Pathologic characteristics of drug-induced lung disease.
@en
type
label
Pathologic characteristics of drug-induced lung disease.
@ast
Pathologic characteristics of drug-induced lung disease.
@en
prefLabel
Pathologic characteristics of drug-induced lung disease.
@ast
Pathologic characteristics of drug-induced lung disease.
@en
P1476
Pathologic characteristics of drug-induced lung disease.
@en
P2093
Douglas B Flieder
William D Travis
P356
10.1016/S0272-5231(03)00138-2
P577
2004-03-01T00:00:00Z